These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23721921)

  • 1. A novel tool for reliable and accurate prediction of renal complications in patients undergoing percutaneous coronary intervention.
    Gurm HS; Seth M; Kooiman J; Share D
    J Am Coll Cardiol; 2013 Jun; 61(22):2242-8. PubMed ID: 23721921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A random forest based risk model for reliable and accurate prediction of receipt of transfusion in patients undergoing percutaneous coronary intervention.
    Gurm HS; Kooiman J; LaLonde T; Grines C; Share D; Seth M
    PLoS One; 2014; 9(5):e96385. PubMed ID: 24816645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Random forest for prediction of contrast-induced nephropathy following coronary angiography.
    Liu Y; Chen S; Ye J; Xian Y; Wang X; Xuan J; Tan N; Li Q; Chen J; Ni Z
    Int J Cardiovasc Imaging; 2020 Jun; 36(6):983-991. PubMed ID: 32285318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel risk score model for prediction of contrast-induced nephropathy after emergent percutaneous coronary intervention.
    Lin KY; Zheng WP; Bei WJ; Chen SQ; Islam SM; Liu Y; Xue L; Tan N; Chen JY
    Int J Cardiol; 2017 Mar; 230():402-412. PubMed ID: 28043662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing definition of contrast-induced nephropathy and its clinical implications: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    Slocum NK; Grossman PM; Moscucci M; Smith DE; Aronow HD; Dixon SR; Share D; Gurm HS
    Am Heart J; 2012 May; 163(5):829-34. PubMed ID: 22607861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel risk score of contrast-induced nephropathy after percutaneous coronary intervention.
    Ji L; Su X; Qin W; Mi X; Liu F; Tang X; Li Z; Yang L
    Nephrology (Carlton); 2015 Aug; 20(8):544-51. PubMed ID: 25706048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preprocedural Prediction Model for Contrast-Induced Nephropathy Patients.
    Yin WJ; Yi YH; Guan XF; Zhou LY; Wang JL; Li DY; Zuo XC
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28159819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors and scoring system in the prediction of contrast induced nephropathy in patients undergoing percutaneous coronary intervention].
    Fu NK; Yang SC; Chen YL; Xu J; Li Q; Li XM; Liu YY; Liu XG; Cong HL
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(8):551-4. PubMed ID: 22490160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serious renal dysfunction after percutaneous coronary interventions can be predicted.
    Brown JR; DeVries JT; Piper WD; Robb JF; Hearne MJ; Ver Lee PM; Kellet MA; Watkins MW; Ryan TJ; Silver MT; Ross CS; MacKenzie TA; O'Connor GT; Malenka DJ;
    Am Heart J; 2008 Feb; 155(2):260-6. PubMed ID: 18215595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal function-adjusted contrast volume redefines the baseline estimation of contrast-induced acute kidney injury risk in patients undergoing primary percutaneous coronary intervention.
    Andò G; de Gregorio C; Morabito G; Trio O; Saporito F; Oreto G
    Circ Cardiovasc Interv; 2014 Aug; 7(4):465-72. PubMed ID: 25027519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between contrast dose and renal complications post PCI across the continuum of procedural estimated risk.
    Kooiman J; Seth M; Share D; Dixon S; Gurm HS
    PLoS One; 2014; 9(3):e90233. PubMed ID: 24625555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
    Worasuwannarak S; Pornratanarangsi S
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merging machine learning and patient preference: a novel tool for risk prediction of percutaneous coronary interventions.
    Hamilton DE; Albright J; Seth M; Painter I; Maynard C; Hira RS; Sukul D; Gurm HS
    Eur Heart J; 2024 Feb; 45(8):601-609. PubMed ID: 38233027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry.
    Mehran R; Owen R; Chiarito M; Baber U; Sartori S; Cao D; Nicolas J; Pivato CA; Nardin M; Krishnan P; Kini A; Sharma S; Pocock S; Dangas G
    Lancet; 2021 Nov; 398(10315):1974-1983. PubMed ID: 34793743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
    Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Two Risk Models in Predicting the Incidence of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention.
    Araujo GN; Wainstein MV; McCabe JM; Huang PH; Govindarajulu US; Resnic FS
    J Interv Cardiol; 2016 Oct; 29(5):447-453. PubMed ID: 27377243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a pre-percutaneous coronary intervention risk model of contrast-induced acute kidney injury with an integer scoring system.
    Inohara T; Kohsaka S; Abe T; Miyata H; Numasawa Y; Ueda I; Nishi Y; Naito K; Shibata M; Hayashida K; Maekawa Y; Kawamura A; Sato Y; Fukuda K
    Am J Cardiol; 2015 Jun; 115(12):1636-42. PubMed ID: 25891989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of nitrates in the prevention of contrast-induced nephropathy in patients hospitalized after undergoing percutaneous coronary intervention.
    Peguero JG; Cornielle V; Gomez SI; Issa OM; Heimowitz TB; Santana O; Goldszer RC; Lamas GA
    J Cardiovasc Pharmacol Ther; 2014 May; 19(3):310-4. PubMed ID: 24367008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHA2DS2-VASc score as a novel predictor for contrast-induced nephropathy after percutaneous coronary intervention in acute coronary syndrome.
    Chaudhary AK; Pathak V; Kunal S; Shukla S; Pathak P
    Indian Heart J; 2019; 71(4):303-308. PubMed ID: 31779857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate.
    Wang XC; Fu XH; Wang YB; Jia XW; Wu WL; Gu XS; Zhang J; Su JL; Hao GZ; Jiang YF; Fan WZ; Li SQ
    Chin Med J (Engl); 2011 Mar; 124(6):892-6. PubMed ID: 21518598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.